CybeRelease: Dr. Tony Martin of (OTC: MNCL) to Speak at the Consumer Health Show to be Held in Toronto
(CybeRelease, March 22, 2007) – Lake Harmony, Pa. - Martin Nutraceuticals Inc. (OTC PK: MNCL) announced that its Director of Research and Development, Dr. Tony Martin been invited to speak at the Consumer Health Show in Toronto. The show is scheduled to take place on April 13th to 15th at the Metro Toronto Convention Centre.
Mr. Harvey Panesar, President of Martin Nutraceuticals Inc. stated, “We are pleased that Tony (Dr. Martin) is being invited to such a highly regarded venue such as the Consumer Health Show being held in Toronto. Dr. Martin is a fantastic public speaker with his sheer charisma and knowledge. The Consumer Health Show gives Martin Nutraceuticals yet another venue to showcase its amazing products and in particular Dr. Martin’s new book, Medical Crisis - Secrets Your Doctor Won’t Share With You. This is all part and parcel of our strategy to bring awareness to Dr. Martin’s new book as we prepare to launch our DRTV (infomercial) campaign.”
The Consumer Health Organization is a non-profit organization committed to making people aware of the “holistic” or “alternative” approach to health. The emphasis is on the prevention of disease through nutrition, whole foods, dietary supplements, herbs and other healing modalities. The Consumer Health Organization can be reached on the World Wide Web at: www.consumerhealth.org. For more information, please contact Investor Relations at (973) 351-3868 or http://www.martinnutra.com/.
About Martin Nutraceuticals Inc.
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.
Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.
To read the complete release, go to http://biz.yahoo.com/bw/070321/20070321006087.html?.v=1.
For a Free Newsletter, go to http://www.OTCReporter.com.
CybeRelease Gainers are Celgene Corporation (Nasdaq: CELG), Varian Semiconductor Equipment Associates, Inc. (Nasdaq: VSEA), Baidu.com, Inc. (Nasdaq: BIDU), GSI Commerce, Inc. (Nasdaq: GSIC), Wynn Resorts, Limited (Nasdaq: WYNN), CompuCredit Corporation (Nasdaq: CCRT), Cephalon, Inc. (Nasdaq: CEPH) and T. Rowe Price Group, Inc. (Nasdaq: TROW).
CybeRelease Decliners are Cintas Corporation (Nasdaq: CTAS), Take-Two Interactive Software, Inc. (Nasdaq: TTWO), Charming Shoppes, Inc. (Nasdaq: CHRS), ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), SimpleTech Inc. (Nasdaq: STEC), Crocs, Inc. (Nasdaq: CROX), Methanex Corporation (Nasdaq: MEOH) and NutriSystem Inc. (Nasdaq: NTRI).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.